Detalles de la búsqueda
1.
Reduced neutralizing activity of post-SARS-CoV-2 vaccination serum against variants B.1.617.2, B.1.351, B.1.1.7+E484K and a sub-variant of C.37
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21260961
2.
The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies that target both the NTD and the RBD
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21253098
3.
SARS-CoV-2 spread across the Colombian-Venezuelan border
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20149856
4.
Intrahost evolution and forward transmission of a novel SARS-CoV-2 Omicron BA.1 subvariant
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22275533
5.
Activity of convalescent and vaccine serum against a B.1.1.529 variant SARS-CoV-2 isolate
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21268134
6.
SARS-CoV-2 variants of concern have acquired mutations associated with an increased spike cleavage
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-455290
7.
Before the Surge: Molecular Evidence of SARS-CoV-2 in New York City Prior to the First Report
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21251303
8.
Robust clinical detection of SARS-CoV-2 variants by RT-PCR/MALDI-TOF multi-target approach
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21263348
9.
Introductions and early spread of SARS-CoV-2 in the New York City area
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20056929
Resultados
1 -
9
de 9
1
Próxima >
>>